Vanda Pharmaceuticals
VNDA
#7861
Rank
C$0.44 B
Marketcap
C$7.45
Share price
3.65%
Change (1 day)
8.74%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.64 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has C$0.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.77 B6.93%
2023-12-31$C$0.72 B1.03%
2022-12-31$C$0.71 B11.17%
2021-12-31$C$0.64 B11.34%
2020-12-31$C$0.57 B7.68%
2019-12-31$C$0.53 B43.06%
2018-12-31$C$0.37 B127.13%
2017-12-31$C$0.16 B-6.4%
2016-12-31$C$0.17 B-4.36%
2015-12-31$C$0.18 B-1.12%
2014-12-31$C$0.18 B297.33%
2013-12-31$C$46.96 M376.88%
2012-12-31$C$9.84 M-71.07%
2011-12-31$C$34.04 M-9.72%
2010-12-31$C$37.71 M55.64%
2009-12-31$C$24.23 M-56.69%
2008-12-31$C$55.95 M-33.01%
2007-12-31$C$83.52 M168.12%
2006-12-31$C$31.15 M-12.74%
2005-12-31$C$35.7 M86.43%
2004-12-31$C$19.14 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
C$61.82 B 9,503.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$32.94 B 5,018.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$109.52 B 16,912.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.69 B 3,891.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 19,877.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
C$3.85 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$71.70 B 11,038.87%๐Ÿ‡บ๐Ÿ‡ธ USA